AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$621M |
| 2 |
Visa
V
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$542M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$525M |
| 5 |
Amazon
AMZN
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$693M |
| 2 |
Texas Instruments
TXN
|
+$477M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$235M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 14.87% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Financials | 12.61% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Universal Insurance Holdings
UVE
$1.21B
| $227K | ﹤0.01% |
17,418
-2,700
| -13% | -$36.8K |
|
3052
KALA BIO
KALA
$12.5M
| $225K | ﹤0.01% |
34
| – | – |
|
|
DHIL
3053
DELISTED
Diamond Hill
DHIL
| $223K | ﹤0.01% |
1,268
-100
| -7% | -$17.5K |
|
|
APLT
3054
DELISTED
Applied Therapeutics
APLT
| $222K | ﹤0.01% |
13,400
| – | – |
|
|
FLIC
3055
DELISTED
First of Long Island Corp
FLIC
| $221K | ﹤0.01% |
10,721
-2,500
| -19% | -$52.5K |
|
3056
Limoneira
LMNR
$242M
| $220K | ﹤0.01% |
13,600
-400
| -3% | -$6.73K |
|
3057
Oramed Pharmaceuticals
ORMP
$170M
| $220K | ﹤0.01% |
10,000
| – | – |
|
3058
Spero Therapeutics
SPRO
$68.3M
| $220K | ﹤0.01% |
11,934
-2,300
| -16% | -$36.9K |
|
3059
Financial Institutions
FISI
$812M
| $218K | ﹤0.01% |
7,100
-1,400
| -16% | -$42.4K |
|
3060
SoundThinking
SSTI
$109M
| $218K | ﹤0.01% |
6,000
-12,871
| -68% | -$540K |
|
3061
Inseego
INSG
$114M
| $217K | ﹤0.01% |
3,260
-805
| -20% | -$67.3K |
|
3062
Donegal Group Class A
DGICA
$701M
| $216K | ﹤0.01% |
14,914
-800
| -5% | -$12K |
|
3063
Toast
TOST
$17.9B
| $216K | ﹤0.01% |
+4,327
| New | +$237K |
|
3064
Methanex
MEOH
$4.19B
| $215K | ﹤0.01% |
+4,669
| New | +$169K |
|
|
KALV
3065
DELISTED
KalVista Pharmaceuticals
KALV
| $213K | ﹤0.01% |
12,200
| – | – |
|
|
DSEY
3066
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $213K | ﹤0.01% |
13,298
+48
| +0.4% | +$795 |
|
3067
EverQuote
EVER
$929M
| $212K | ﹤0.01% |
11,400
-1,400
| -11% | -$33.5K |
|
3068
Accel Entertainment
ACEL
$1.01B
| $211K | ﹤0.01% |
17,400
| – | – |
|
3069
Metallus
MTUS
$869M
| $211K | ﹤0.01% |
16,165
-6,750
| -29% | -$92.4K |
|
3070
Clarus
CLAR
$126M
| $209K | ﹤0.01% |
8,145
| – | – |
|
|
ZEUS
3071
DELISTED
Olympic Steel
ZEUS
| $209K | ﹤0.01% |
8,590
-1,840
| -18% | -$50.8K |
|
|
TPC
3072
Tutor Perini Cor
TPC
$4.51B
| $209K | ﹤0.01% |
16,095
-2,400
| -13% | -$32.8K |
|
|
EIGR
3073
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $209K | ﹤0.01% |
1,043
| – | – |
|
3074
Luxfer Holdings
LXFR
$462M
| $208K | ﹤0.01% |
10,613
-1,200
| -10% | -$24.8K |
|
|
AXDX
3075
DELISTED
Accelerate Diagnostics
AXDX
| $206K | ﹤0.01% |
3,531
-250
| -7% | -$16.3K |
|
Similar funds
AllianceBernstein's Q3 2021 Portfolio in Review
As of Q3 2021, AllianceBernstein held 3,430 positions worth $253B, up 1.8% from $249B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AllianceBernstein's Q3 2021 filing shows 114 new, 1,102 increased, 1,623 reduced and 152 closed positions. Its largest new stake was Freshworks: 2,094,708 shares worth $89.4M. The largest sale was Alphabet (Google) Class C, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q3 2021 buy was Freshworks: 2,094,708 shares worth $89.4M.
- AllianceBernstein added most to Qualcomm in Q3 2021, an estimated $621M increase.
- AllianceBernstein's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $693M.
- AllianceBernstein fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $230M.
- AllianceBernstein's ten largest holdings make up 25% of its $253B portfolio in Q3 2021.
- AllianceBernstein opened 114 new positions and closed 152 in Q3 2021.
- AllianceBernstein's portfolio value rose 1.8% quarter-over-quarter to $253B.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.